載入...
Repurposing Established Compounds to Target Pancreatic Cancer Stem Cells (CSCs)
The diagnosis of pancreatic ductal adenocarcinoma (PDAC) carries a dismal prognosis, in particular, when patients present with unresectable disease. While significant progress has been made in understanding the biology of PDAC, this knowledge has not translated into a clear clinical benefit and curr...
Na minha lista:
| 發表在: | Med Sci (Basel) |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5635789/ https://ncbi.nlm.nih.gov/pubmed/29099030 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/medsci5020014 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|